GREY:VDQSF - Post by User
Comment by
SizzlinSteakson Dec 16, 2017 12:07am
52 Views
Post# 27170080
RE:RE:Pp close
RE:RE:Pp closePerhaps this is also a large reason why the SP hasn't yet taken off. I see they initially announced a finacing raise back in June but it hasn't closed until now. A previous update stated the summer drop in valuations has delayed due dilligence affecting their financing. Hence concern surrounding capital likely stumped the SP. Now that it is closed, cash is secured for completion of their new facility and the SP should be free to run. Looking forward to seeing how this plays out over the next while.
SizzlinSteaks wrote: Thanks for posting. This is great news. Also bodes well that an insider takes 1.3 million shares of the PP. Hopefully they can wrap up the expansion now and get rolling in Bellingham.
Vodis closes private placement for $2.01-million
2017-12-15 19:58 ET - News Release
Mr. Ivan Miliovski reports
VODIS ANNOUNCES CLOSING OF PRIVATE PLACEMENT
Vodis Pharmaceuticals Inc. has closed a non-brokered private placement of 8.06 million units at a price of 25 cents per offered unit for gross proceeds of $2,015,000. The proceeds from the Offering will be used to complete the expansion of the Company's facility in Bellingham, Washington, and the process of upgrading its Delta, BC, location, and for general working capital and corporate purposes.
Each Offered Unit consisted of one common share of the Company and one common share purchase warrant, whereby each warrant entitles the holder thereof to acquire one additional common share of the Company at a price of $0.33 for a period of five (5) years from the date of issuance. All securities issuable in connection with the Offering are subject to a statutory hold period of four months following the date of issuance.
A director of the Company participated in the Offering by purchasing an aggregate of 1,300,000 Offered Units. Accordingly, the Offering constituted to that extent a related party transaction as defined under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (" MI 61-101 "). The transaction is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of any shares issued to, nor the consideration paid by such person, exceeded 25% of the Company's market capitalization. Further, neither the Company nor the related party has knowledge of any material information concerning the Company or its securities that has not been generally disclosed.